Factors associated with completion of bowel cancer screening and the potential effects of simplifying the screening test algorithm

British Journal of Cancer

Volumn 114, Issue 3, 2016, Pages 327-333

  Kearns, Benjamin ^a   Whyte, Sophie ^a   Seaman, Helen E ^b   Snowball, Julia ^b   Halloran, Stephen P ^b,c   Butler, Piers ^b   Patnick, Julietta ^d   Nickerson, Claire ^d   Chilcott, Jim ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b NHS Bowel Cancer Screening Southern Programme Hub   (United Kingdom)

^c UNIVERSITY OF SURREY   (United Kingdom)

^d PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Colorectal neoplasm; compliance; drop out; England; faecal occult blood test; mass screening

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER SCREENING; CLINICAL EFFECTIVENESS; COLORECTAL CANCER; DIAGNOSTIC KIT; FEMALE; FOLLOW UP; GUAIAC FECAL OCCULT BLOOD TEST; GUAIAC FECAL OCCULT BLOOD TEST KIT; HUMAN; MAJOR CLINICAL STUDY; MALE; NATIONAL HEALTH SERVICE; OCCULT BLOOD TEST; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PATIENT REFERRAL; PRIORITY JOURNAL; PROGRAM EFFECTIVENESS; SEX; SOCIAL STATUS; ALGORITHM; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY CANCER DIAGNOSIS; ENGLAND; MIDDLE AGED; OCCULT BLOOD; PROCEDURES; SEX DIFFERENCE; SOCIAL CLASS; STATISTICS AND NUMERICAL DATA; UTILIZATION;

AGE FACTORS; AGED; ALGORITHMS; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; ENGLAND; FEMALE; HUMANS; MALE; MIDDLE AGED; OCCULT BLOOD; PATIENT COMPLIANCE; REFERRAL AND CONSULTATION; SEX FACTORS; SOCIAL CLASS; STATE MEDICINE;

EID: 84956760467     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2015.469     Document Type: Article

References (40)

1. Altobelli E, Lattanzi A, Paduano R, Varassi G, di Orio F. (2014). Colorectal cancer prevention in Europe: burden of disease and status of screening programs. Prev Med 62: 132-141.
2. Asaria M, Griffin S, Cookson R, Whyte S, Tappenden P. (2014). Distributional Cost-Effectiveness Analysis of Health Care Programmes' A Methodological Case Study of the UK Bowel Cancer Screening Programme. Health Econ. 24(6): 742-754.
3. Aubin-Auger I, Mercier A, Lebeau JP, Baumann L, Peremans L, Van Royen P. (2011). Obstacles to colorectal screening in general practice: a qualitative study of GPs and patients. Fam Pract. 28(6): 670-676.
4. Benson VS, Atkin WS, Green J, Nadel MR, Patnick J, Smith RA, Villain P. (2012). Toward standardizing and reporting colorectal cancer screening indicators on an international level: the International Colorectal Cancer Screening Network. Int J Cancer. 130(12): 2961-2973.
5. Beydoun HA, Beydoun MA. (2008). Predictors of colorectal cancer screening behaviors among average-risk older adults in the United States. Cancer Causes Control. 19(4): 339-359.
6. Birkenfeld S, Belfer RG, Chared M, Vilkin A, Barchana M, Lifshitz I, Fruchter D, Aronski D, Balicer R, Niv Y. (2011). Factors affecting compliance in faecal occult blood testing: a cluster randomized study of the faecal immunochemical test versus the guaiac faecal occult test. J Med Screen. 18(3): 135-141.
7. Bowel Cancer Screening Southern Programme Hub. (2014). Bowel Cancer Screening Southern Programme Hub'Summary report: 2012-2013. Available at http://royalsurrey.staging.flipsidegroup.com/bowel-cancerscreening-southern-hub (accessed 28 December 2015).
8. Bowel Cancer Screening Southern Programme Hub. (2015). Bowel Cancer Screening Southern Programme Hub'Summary report: 2013-2014. Available at http://royalsurrey.staging.flipsidegroup.com/bowel-cancerscreening-southern-hub (accessed 28 December 2015).
9. Brouse CH, Basch CE, Wolf RL, Shmukler C, Neugut AI, Shea S. (2003). Barriers to colorectal cancer screening with fecal occult blood testing in a predominantly minority urban population: a qualitative study. Am J Public Health. 93(8): 1268-1271.
10. Cancer Research UK. (2013). Cancer Statistics: Key Facts: Bowel Cancer April 2013.
11. Communities and Neigbourhoods. (2010). Indices of Deprivation 2007. Department for Communities and Local Government
12. Fraser CG, Digby J, McDonald PJ, Strachan JA, Carey FA, Steele RJ. (2012). Experience with a two-Tier reflex gFOBT/FIT strategy in a national bowel screening programme. J Med Screen. 19(1): 8-13.
13. Geraghty J, Butler P, Seaman H, Snowball J, Sarkar S, Blanks R, Halloran S, Bodger K, Rees C. (2014). Optimising faecal occult blood screening: retrospective analysis of NHS Bowel Cancer Screening data to improve the screening algorithm. Br J Cancer. 111(11): 2156-2162.
14. Geurts SME, Massat NJ, Duffy SW. (2015). Likely effect of adding flexible sigmoidoscopy to the English NHS Bowel Cancer Screening Programme: impact on colorectal cancer cases and deaths. Br J Cancer. 113(1): 142-149.
15. Gupta S. (2008). Will test-specific adherence predict the best colorectal cancer screening strategy?. Ann Intern Med. 149(9): 659-669.
16. Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, James PD, Mangham CM. (1996). Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 348(9040): 1472-1477.
17. Heslop P, Blair P, Fleming P, Hoghton M, Marriott A, Russ L. (2013). Confidential inquiry into premature deaths of people with learning disabilities (CIPOLD): final report. Available at www.bristol.ac.uk/cipold/.fullfinalreport.pdf (accessed 28 December 2015).
18. Hewitson P, Glasziou P, Watson E, Towler B, Irwig L. (2008). Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol. 103(6): 1541-1549.
19. Honein-AbouHaidar GN, Kastner M, Vuong V, Perrier L, Rabeneck L, Tinmouth J, Straus S, Baxter NN. (2014). Benefits and barriers to participation in colorectal cancer screening: a protocol for a systematic review and synthesis of qualitative studies. BMJ Open. 4(2): e004508.
20. Kearns B, Whyte S, Chilcott J, Patnick J. (2014). Guaiac faecal occult blood test performance at initial and repeat screens in the English Bowel Cancer Screening Programme. Br J Cancer. 111(9): 1734-1741.
21. Kewenter J, Brevinge H, Engaras B, Haglind E, Ahran C. (1994). Results of screening, rescreening, and follow-up in a prospective randomized study for detection of colorectal cancer by fecal occult blood testing: results for 68,308 subjects. Scand J Gastroenterol. 29(5): 468-473.
22. Kronborg O, Fenger C, Olsen JA, Jargensen OD, Sandergaard O. (1996). Randomised study of screening for colorectal cancer with faecal-occultblood test. Lancet. 348(9040): 1467-1471.
23. Lo SH, Halloran S, Snowball J, Seaman H, Wardle J, Von Wagner C. (2014). Predictors of repeat participation in the NHS bowel cancer screening programme. Br J Cancer. 112(1): 199-206.
24. Lo SH, Halloran S, Snowball J, Seaman H, Wardle J, von Wagner C. (2014). Colorectal cancer screening uptake over three biennial invitation rounds in the English bowel cancer screening programme. Gut. 64(2): 282-291.
25. Logan RF, Patnick J, Nickerson C, Coleman L, Rutter MD, von Wagner C. (2012). Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests. Gut. 61(10): 1439-1446.
26. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, Ederer F. (1993). Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med. 328(19): 1365-1371.
27. Moss S, Mathews C, Day T, Smith S, Halloran SP. (2015). OC-002 Increased participation in colorectal cancer screening during a pilot of faecal immunochemical test for haemoglobin (FIT) in england. Gut 64(Suppl 1): A1.
28. Moss SM, Campbell C, Melia J, Coleman D, Smith S, Parker R, Ramsell P, Patnick J, Weller DP. (2012). Performance measures in three rounds of the English bowel cancer screening pilot. Gut. 61(1): 101-107.
29. NHS Bowel Cancer Screening Programme (2011). In the loop newsletter for people working in the NHS Bowel Cancer Screening Programme, Winter 2010/2011, pp 1-4.
30. Pornet C, Dejardin O, Morlais F, Bouvier VA, Launoy G. (2010). Socioeconomic determinants for compliance to colorectal cancer screening. A multilevel analysis. J Epidemiol Community Health. 64(4): 318-324.
31. Robb KA, Power E, Atkin W, Wardle J. (2008). Ethnic differences in participation in flexible sigmoidoscopy screening in the UK. J Med Screen. 15(3): 130-136.
32. Robinson MHE, Moss SM, Hardcastle JD, Whynes DK, Chamberlain JO, Mangham CM. (1995). Effect of retesting with dietary restriction in Haemoccult screening for colorectal cancer. J Med Screen. 2(1): 41-44.
33. Shankaran V, McKoy JM, Dandade N, Nonzee N, Tigue CA, Bennett CL, Denberg TD. (2007). Costs and cost-effectiveness of a low-intensity patientdirected intervention to promote colorectal cancer screening. J Clin Oncol. 25(33): 5248-5253.
34. Sicsic J, Franc C. (2014). Obstacles to the uptake of breast, cervical, and colorectal cancer screenings: what remains to be achieved by French national programmes?. BMC Health Serv Res. 14(1): 465.
35. Smith SK, Simpson JM, Trevena LJ, McCaffery KJ. (2014). Factors associated with informed decisions and participation in bowel cancer screening among adults with lower education and literacy. Med Decis Making. 34(6): 756-772.
36. UK Colorectal Cancer Screening Pilot Group. (2004). Results of the first round of a demonstration pilot of screening for colorectal cancer in the United Kingdom. BMJ. 329(7458): 133.
37. Von Wagner C, Good A, Wright D, Rachet B, Obichere A, Bloom S, Wardle J. (2009). Inequalities in colorectal cancer screening participation in the first round of the national screening programme in England. Br J Cancer 101: S60-S63.
38. von Wagner C, Baio G, Raine R, Snowball J, Morris S, Atkin W, Obichere A, Handley G, Logan RF, Rainbow S. (2011). Inequalities in participation in an organized national colorectal cancer screening programme: results from the first 2.6 million invitations in England. Int J Epidemiol. 40(3): 712-718.
39. von Wagner C, Semmler C, Good A, Wardle J. (2009). Health literacy and self-efficacy for participating in colorectal cancer screening: the role of information processing. Patient Educ Couns. 75(3): 352-357.
40. Weller DP, Campbell C. (2009). Uptake in cancer screening programmes: a priority in cancer control. Br J Cancer 101: S55-S59.